In Vitro and In Vivo Studies of AT-1362, a Newly Synthesized and Orally Active Inhibitor of Thrombin

By Cho J.-h.   Seo H.-s.   Yun C.-h.   Koo B.-a.   Yoshida S.   Koga T.   Dan T.   Kim H.-y.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 97-107

Elsevier

Access to resources Recommend Favorite

Changes of Platelet Surface Antigens in Patients Suffering from Abdominal Septic Shock - An orally active inhibitor op platelet aggregation

By Salat A.   Bodingbauer G.   Boehm D.   Murabito M.   Tochkow E.   Sautner T.   R Mueller M.   Fuegger R.  

Thrombosis Research, Vol. 95, Iss. 6, 1999-09 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite

Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy

By Li F.   Szabó C.   Pacher P.   Southan G.   Abatan O.   Charniauskaya T.   Stevens M.   Obrosova I.  

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 710-717

Springer Publishing Company

Access to resources Recommend Favorite

LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis

By Ribeiro Grazielle Alves   Cunha-Júnior Edézio Ferreira   Pinheiro Roberta Olmo   da-Silva Silvia Amaral Gonçalves   Canto-Cavalheiro Marilene Marcuzzo   da Silva Alcides José Monteiro   Costa Paulo Roberto R.   Netto Chaquip Daher   Melo Rossana C. N.   Almeida-Amaral Elmo Eduardo   Torres-Santos Eduardo Caio  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 4, 2013-04 ,pp. : 789-799

Oxford University Press

Access to resources Recommend Favorite

Pharmacological Characterization of a Novel Factor Xa Inhibitor, FXV673

By Chu V.   Brown K.   Colussi D.   Gao J.   Bostwick J.   Kasiewski C.   Bentley R.   Morgan S.   Guertin K.   Pauls H.W.   Gong Y.   Zulli A.   Perrone M.H.   Dunwiddie C.T.   Leadley R.J.  

Thrombosis Research, Vol. 103, Iss. 4, 2001-08 ,pp. : 309-324

Elsevier

Access to resources Recommend Favorite